Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is:

Similar documents
Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018

Update on Spitzoid and Blue nevus-like melanocytic lesions Emphasis on molecular studies informing diagnosis, prognosis and therapy

Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is:

Michael T. Tetzlaff MD, PhD

Melanoma and the genes: Molecular alterations informing the diagnosis of melanocytic tumors

6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms

The Enigmatic Spitz Lesion

Melanocytic proliferations in sundamaged

Conflict of Interest 9/2/2014. Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma

Melanocytic Tumours. Molecular Biology 02/06/2015. Cutaneous Melanocytic Tumours Introduction. Thomas Brenn. Intermediate Malignancy

Case 231: F7. Exophytic naevus over left trapezious. Grown over a few weeks. Iniitally flat.?spitz naevus,?malignant

Vernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

MAPK Pathway. CGH Next Generation Sequencing. Molecular Tools in Care of Patients with Pigmented Lesions 7/20/2017

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

Case RAC7783. M46. Ear. Mole. r/o MM.?Blue naevus RAC7783

There is NO single Melanoma Stain. > 6000 Mutations in Melanoma. What else can be done to discriminate atypical nevi from melanoma?

A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment

The Pathology of Neoplasia Part II

Page 1 of 3. We suggest the following changes:

Conflicts of Interest

Diagnosis of melanocytic proliferations remains one of

DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES

I have no relevant conflicts of interest to disclose. John T. Seykora MD PhD Departments of Dermatology & Pathology and Laboratory Medicine

10/2/17. MELTUMP, SAMPUS, AST.An Algorithmic Approach to Challenging (Often Borderline) Melanocytic Tumors. An Introduction to SNP Arrays

2/6/2018. Original Paradigm. Clonal Chromosomal A berrations. Only 20% of Spitz Nevi 95% 6p, 7q, 17q, 20q, 4q,8q, 1q, 11q. Isolated Gain in 11p

21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells

Integrating Fluorescence in situ Hybridization and Genomic Array Results into the Diagnostic Workup of Melanoma

Molecular Aspects of Melanocytic Neoplasia. Iwei Yeh MD, PhD University of California, San Francisco

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

K Blessing, J J H Grant, D S A Sanders, M M Kennedy, A Husain, P Coburn

Artur Zembowicz, MD, PhD; Sung-Eun Yang, MD; Antonios Kafanas, MD; Stephen R. Lyle, MD, PhD

Dermatologica Sinica

S everal morphological features are frequently used in the

Blue Melanocytic Proliferations

Pathological diagnosis of melanocytic tumours: clues and pitfalls # Richard A. Scolyer 1,2,3* and Stanley W. McCarthy 1,2,3

Ways to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble at bay

Difficulties in the diagnosis of spitzoid melanocytic lesions

Management of pediatric melanocytic lesions

ACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016

Spitz nevi in the classic histopathological pattern - lamb in wolf`s clothing *

STUDY. Sensitivity of Fluorescence In Situ Hybridization for Melanoma Diagnosis Using RREB1, MYB, Cep6, and 11q13 Probes in Melanoma Subtypes

Time to reconsider Spitzoid neoplasms?

Rosette-like structures in the spectrum of spitzoid tumors

Introduction. Cesinaro A M, Schirosi L, Bettelli S, Migaldi M & Maiorana A (2010) Histopathology 57,

Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia

57th Annual HSCP Spring Symposium 4/16/2016

Malignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha

Guy Perrot (Ги Перро)

> 6000 Mutations in Melanoma. Tests That Cay Be Employed. FISH for Additions/Deletions. Comparative Genomic Hybridization

THE SPITZ NEVUS OFTEN POSES

Self assessment case. Dr Saleem Taibjee Dorset County Hospital, Dorchester

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology

Supplementary Figure 1. Spitzoid Melanoma with PPFIBP1-MET fusion. (a) Histopathology (4x) shows a domed papule with melanocytes extending into the

Approximately 2% of the United States population

المركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Case 4 Diagnosis 2/21/2011 TGB

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Less Common Variants of Cutaneous Melanoma

F006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations

Cellular Neurothekeoma

Histopathology: skin pathology

BAP-oma & BEYOND MICHAEL A NOWAK, MD

Desmoplastic Melanoma: Clinical Behavior and Management Implications

A 25 year old female with a palpable mass in the right lower quadrant of her abdomen

Society for Pediatric Pathology Spring Meeting Joint Symposium with American Society of Dermatopathology

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma

Simulators of melanoma

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

My approach to atypical melanocytic lesions. J Clin Pathol 2004;57: doi: /jcp

The Dermal Melanocytoses. Conflicts of Interest 5/22/2018. The Nevi of Ota and Ito. Martin C. Mihm M.D.

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS

Melanocytic lesions on Genital Skin Melanoma vs. Melanocytic Nevus, Revisited. Timothy H. McCalmont, MD University of California, San Francisco

Case 27 Male 42. Painless, static, well-circumscribed, subcutaneous nodule right lower leg,?lipoma. The best diagnosis is:

5/21/2018. Disclosures. Consulting: Myriad Genetics SciBase. Superficial Atypical Melanocytic Proliferations. SSM, LMM and (some of) their Simulants

Solid Tumour Section Review

HISTOPATHOLOGIC REPORTING OF MELANOCYTIC SKIN LESIONS. Problems, thoughts, proposals

International Society of Gynecological Pathologists Symposium 2007

EARLY ONLINE RELEASE

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

State of the Art, Nomenclature, and Points of Consensus and Controversy Concerning Benign Melanocytic Lesions: Outcome of an International Workshop

Basal cell carcinoma 5/28/2011

Diagnostic problems in uterine smooth muscle tumors

BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance

Histopathology of Melanoma

BSD 2015 Case 19. Female 21. Nodule on forehead. The best diagnosis is:

Paediatric Dermatology Column: Case Report. Paediatric melanoma: challenges in diagnosis and management

Special slide seminar

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Until recently, the prevailing paradigm in classification

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Transcription:

Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is: A. Desmoplastic Spitz naevus B. Atypical Spitz Tumour C. Spitzoid melanoma D. Deep penetrating naevus E. Spitz naevus

Case 26: M 37. Right jawline 5mm nodule?keloid

Case 26: M 37. Right jawline 5mm nodule?keloid

S100 useful for architecture

Ill-defined deep border, some lack of maturation

mitoses and nuclear pleomorphism

Case 26: M 37 Diagnosis? p16 variable expression Ki67 low (5%)

Atypical Spitz tumour:? slightly favouring benign

Case 26: atypical Spitz tumour Differential diagnosis: desmoplastic Spitz naevus Similar but more sclerotic stroma, less atypia

Case 26: atypical Spitz tumour Differential diagnosis: Spitzoid melanoma Similar but more atypia, asymmetry, mitoses etc.

Differential diagnosis: Spitzoid melanoma Similar but more atypia, asymmetry, mitoses etc. Slides courtesy of melanocytepathology.com Free access site by Prof Wolter Mooi, 2013 BSD guest speaker

Differential diagnosis: deep penetrating naevus wedge-shaped, less atypia

Case 26: atypical Spitz tumour Differential diagnosis: deep penetrating naevus wedge-shaped, less atypia,

Differential diagnosis: Spitz naevus more symmetry, clefts surrounding nests, Kamino bodies, less atypia

Case 26: atypical Spitz tumour Differential diagnosis: Spitz naevus more symmetry, less atypia,

FISH results Vysis Melanoma FISH Probe Kit Total Value Parameters +/- (Gerami et al.am J Surg Pathol 2008;33:1146-1156) % of nuclei with > 2 CCND1 signals 1 3.33% Cut-off >/- 38.00% - % of nuclei with > 2 RREB1 signals 0 0.00% Cut-off >/- 29.00% - % of nuclei with gain of RREB1 relative to CEP6 5 16.67% Cut-off >/- 55.00% - % of nuclei with loss of MYB (6q23) relative to CEP6 17 56.67% Cut-off >/- 40.00% + Abbott Average CCND1 signals per nucleus 50 1.67 Cut-off >/- 2.50 - % of atypical nuclei (signals/nucleus >or<2) for RREB1 10 33.33% Cut-off >/- 63.00% - Average MYB signals per nucleus 37 2.23 Cut-off >/- 2.50 - % of nuclei with loss of MYB (6q23) 8 relative to CEP6 17 56.67% Cut-off >/- 31.00% + FISH positive for 6q23 loss with both probe kits FISH courtesy of JE Calonje

Case 26: M 37. Final diagnosis? Atypical Spitz tumour with 6q23 deletion

Atypical spitz tumors with 6q23 deletions: a clinical, histological, and molecular study. Shen L, Cooper C, Bajaj S, Liu P, Pestova E, Guitart J, Gerami P. Am J Dermatopathol. 2013 Dec;35(8):804-12 retrospective case-controlled study probes targeting 6p25, 6q23, Cep6, 11q13, 9p21, and Cep9. 24 cases of atypical Spitz tumours (ASTs) with isolated copy number deletions in 6q23 6 of 11 patients had a positive sentinel node biopsy, BUT none of the patients developed tumor in a non-sentinel node, palpable adenopathy, in transit metastasis, or distant metastasis BUT mean follow up only 22 months (2 of 3 cases with at least 5 yrs had positive sentinel node)

Atypical spitz tumors with 6q23 deletions: a clinical, histological, and molecular study. Shen L, Cooper C, Bajaj S, Liu P, Pestova E, Guitart J, Gerami P. Am J Dermatopathol. 2013 Dec;35(8):804-12 Can we predict the deletion histologically? NO! minimal pagetoid spread (P = 0.004) expansile nodular growth (P = 0.08) focal ulceration (P = 0.19)

Atypical Spitz tumours with possible good prognosis: 3p21 and 6q23 loss 3p21 (BAPoma / BAP1 associated Spitz tumour) 6q23 but is it really a good prognosis? as 6 of 11 patients had a positive sentinel node biopsy! Both can show much cytological atypia

Atypical Spitz tumours with possible poor prognosis: HOMOZYGOUS 9p21 loss, 6p25gain, 11q13 gain Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, Prieto VG, Leboit PE, Barnhill RL, Cooper C, Yazdan P, Guitart J, Liu P, Pestova E, Busam K. Am J Surg Pathol. 2013 May;37(5):676-84. FISH detecting a limited number of chromosomal copy number aberrations can provide clinically useful and statistically significant risk assessment for atypical Spitz tumors. In multivariate analysis, homozygous 9p21 deletion was highly associated with clinically aggressive behavior (P<0.0001) and death due to disease (P=0.003). Cases with 6p25 or 11q13 gains also have higher risk for aggressive clinical behavior than FISH-negative atypical Spitz tumors or cases with 6q23 deletions.

Atypical Spitz tumours with possible poor prognosis: HOMOZYGOUS 9p21 loss, 6p25gain, 11q13 gain HOMOZYGOUS 9p21 loss Severe cytologic atypia predominance of epithelioid cytomorphology increased dermal mitotic activity p16-100% of cases had areas with complete loss of staining

Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is: A. Desmoplastic Spitz naevus B. Atypical Spitz Tumour C. Spitzoid melanoma D. Deep penetrating naevus E. Spitz naevus